Avidity Biosciences
RNA
#1835
Rank
C$14.91 B
Marketcap
C$98.96
Share price
0.13%
Change (1 day)
91.36%
Change (1 year)

Market capitalization of Avidity Biosciences (RNA)

Market cap: C$14.91 Billion

As of December 2025 Avidity Biosciences has a market cap of C$14.91 Billion. This makes Avidity Biosciences the world's 1835th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Avidity Biosciences from 2020 to 2025

End of year Market Cap

Year Marketcap Change
2025C$14.91 B189.24%
2024C$5.15 B442.41%
2023C$0.95 B-52.51%
2022C$2.00 B40.87%
2021C$1.42 B16.34%
2020C$1.22 B

End of Day market cap according to different sources

On Dec 5th, 2025 the market cap of Avidity Biosciences was reported to be:

C$14.91 Billion
by Nasdaq info icon info icon
C$14.91 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
PTC Therapeutics
PTCT
C$8.56 B-42.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
C$1.13 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
C$3.22 B-78.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
C$3.99 B-73.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
C$0.17 B-98.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
C$15.10 B 1.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$204.46 B 1,271.26%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
C$134.99 B 805.40%๐Ÿ‡ฌ๐Ÿ‡ง UK